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Quality of Life After Bilateral Adrenalectomy in MEN 2
M. Telenius-Berg,* M.A. Ponder,* B. Berg,* B.A.J. Ponder,* and S. Werner§

Pheochromocytoma is a major cause of morbidity and monality in the multiple endocrine neoplasia
type 2 (MEN 2) syndrome. For the physician, surgical treatment seems well justified even ihough
bilateral adrenalectomy will induce iatrogenically complete loss of adrenocortical function. For the
patient this treatment may be a cause of medical problems as weU as worry. We have evaluated quality
of life afler bilateral adrenalectomy in 27 MEN 2 patients through a combined oral and written
approach. Mortality was low (one of 27), as was serious morbidity. Most patients had adapted well lo
theposladrenalectomy slale. However, fatigue, worry, and noncompliance with daily medication often
caused problems. (Henry Ford Hosp Med J 1989;37:160-3)

C

omptete lack of endogenous production of adrenocortical
steroids is considered a significant health handicap. Because pheochromocytomas are potentially life-threatening tumors, the benefit of adrenalectomy outweighs the iatrogenic
handicap of comptete adrenocortical failure. The clinical management of adrenal disease in muttiple endocrine neoplasia type
2 (MEN 2) is controversial. Surgical treatment is safe in that the
risk for recunence of pheochromocytoma is low. Bilateral adrenalectomy is therefore recommended even when there is only
unilateral involvement, van Heerden et al (I) found a low
morbidity and mortality in their patients after bilateral
adrenalectomy.
We have advocated a more conservative approach, using one
of two different techniques. The first atternative is unilateral
adrenalectomy, after which the patient is closely followed.
When evidence of tumor in the contralateral adrenal gland is
found, the patient witl have the second, ie, final, adrenalectomy
(2). Because pheochromocytomas in MEN 2 rarely are malignant, we have considered an even more conservative approach as
justified in a pilot study for suitable patients. This second atternative is subtotal adrenalectomy in which the pheochromocytoma is removed along with the adrenal medulla and most
ofthe cortex. The remaining adrenocorticalfissueis left in situ
as a vascularized rim (3). Our choice of these strategies is based
on tumor development in the adrenals being frequently
asynchronous. Unilateral adrenalectomy may give the patient
several years of freedom from replacement with corticosteroid
hormones. Many patients have already had a total thyroidectomy for medullary carcinoma for which they receive replacement therapy with 1-thyroxin. However, the adrenal treatment is
more complicated and demands more understanding and cooperation from the patient.
The international debate about the management of pheochromocytoma confirms that this is a difficult issue (1). We
therefore feet that more information is needed to establish safe
guidelines for the management of MEN 2 pafients. As availability of medical care may vary in different parts of the world, there
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is need for a choice of options in different countries. Moreover,
not onty physicians but atso the pafients themselves have great
concern about the loss of adrenal function which necessitates
complete dependence on exogenous corticosteroids supplied
daily in divided doses. Some of our patients have been so worried about these prospects that they have delayed, and a few have
even declined, bilateral adrenalectomy.
The aim of this ongoing study is to assess quality of life after
bilateral adrenalectomy from analysis of data on the medical
(somafic and psychological) consequences as wett as the practical inconveniences that patients encounter. We present our first
results on these patients' initiat concem about future practical
problems and their psychological adaptation (Table).

Patients, Materials, and Methods
We examined 27 MEN 2 patients after bilateral adrenalectomy (13 Swedish, 13 British, and one Syrian resident in
Kuwait). At the time of the investigation most patients were of
middle age (median age 52 years, range 20 to 73 years). Two
patients were deceased at the time of this study; both had been
followed by one of us (MTB), and their problems were well
known. Since most patients had had surgery several years earlier
(median follow-up 6 years, range 4 months to 28 years), they
had had ample time to adapt to their situafion.
Eighteen or two-thirds of the patients had their adrenal tumors
diagnosed as a result of family screening, whereas nine or one-
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Table
Important Issues for Patient Information Before Bilateral
Adrenalectomy

Per cent

Degree of physical handicap
Problems wilh dmg intake
Qualily of medical care
Problems coping with job
Psychological distress and worry

third were diagnosed because of clinical symptoms only. However, 21 (76%) of the 27 patients had classical symptoms of
pheochromocytoma before surgery. They were therefore well
motivated for surgery and probably had a positive attitude toward enduring the hardships of being adrenalectomized.
Information was compiled from the patients themselves, as
well as fromfirst-degreerelatives, and in some cases from the
physicians involved. The patients were interviewed twice, first
via a written questionnaire and then orally. The same protocol
was followed for the oral interview with the possibility to add
information not covered by the questionnaire. If the patients
were not followed by one of us, their physicians were also interviewed. First-degree relatives of the deceased patients were interviewed and asked to answer as they thought the patients
would have done. The questions were chosen so as to give answers to specific objects of concem for the treating physicians as
well as for the patients themselves. The answers were graded either dichotomously (yes/no) or according to a scate (0-2).

Results
The written and oral examinations gave similar results, ie,
consistency and reproducibility were satisfactory. The prevalences for difficulties within the problem areas are presented in
the Figure (compare with the Table).
Degree of physical handicap
Medical problems related to the adrenalectomy or the lack of
endogenous producrion of corticosteroids and leading to extraordinary hospital admissions were encountered in nine (33%)
of the 27 patients. This percentage includes one postoperafive
death. This 74-year-oId man had an uneventful immediate
postoperative course, but ten days after bilateral adrenalectomy
he suffered a massive hematemesis and ultimately died in multiorgan failure. His pheochromocytoma had been detected 14
years earlier, but he had declined operation for both the adrenal
and thyroid tumors since he had had no subjective symptoms for
the first 12 years.
This frequency of hospital admissions does not include office
visits for routine care or for adjustment of corticosteroid replacement, nor routine shift to parenteral therapy during gastrointesfinal upsets or other intercunent disease. Other somatic
medical problems encountered were long-lasting fafigue, backache, impaired tolerance (to infections, stress, and tow carbohydrate intake), hypoglycemia, and hyperpigmentafion. Further
analysis ofthe medical problems will be reported separately.
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Figure—Problems met by MEN 2 patients after bilateral adrenalectomy. Y axis; Fraction of patients with problems. X axis;
Physical and medical problems, medical care, problems with
medication in emergency, problems with medication in gastrointestinal upsets, problems in remembering to take medication, problems in daily work, and worry about medical
complications.

Problems with drug intake
Medical complications may be related to difficulties or noncompliance in taking medicines as prescribed. Eleven (42%) of
26 patients had difficulty remembering to take their medications. Two patients indicated that this occurred "often,"
whereas the others answered "sometimes" or "occasionally."
One patient had made it a routine to take the complete 24-hour
dose once daily because of her forgetfulness. One patient
stopped taking her medicines when she became depressed. This
type of problem was considered clinically significant by the
treating physicians in only two cases. Most pafients said they
would increase or double the dose if they had forgotten to take
the tablets.
Four (16%) of 25 patients reported difficulty taking medicines
during an emergency, and seven (28%) of the 25 patients had
such problems during gastrointestinal upsets. However, only
three (12%) of these pafients viewed such problems as having a
negafive impact on their quality of life.
Quality of medical care
All but one patient were satisfied as having good and continuous health care and being seen regularly by competent medical
specialists (many of whom have a special interest in MEN 2).
Most patients lived only a short distance from the nearest hospital. Five patients lived more than 50 km away, including one
British missionary in Africa who had to travel at least 320 km to
reach a hospital.
Problems coping with work
Seven of 24 patients reported problems of excessive long-lasting fatigue after the adrenalectomy which created difficulty in
coping with the same workload as before adrenalectomy. A few
patients felt that one to two years of partial sick leave woutd have
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been adequate for full adaptation. However, two-thirds of the patients reported no problems in coping with work.
Psychological distress and worry
A totat of 48% of the patients did not regard their condition as
a reat handicap, 8% had no decided opinion, while 44% considered themselves more or less handicapped. A total of 18% reported intense worry about their condition, 50% reported slight
to moderate wony, and 42% said they did not worry at all. However, when asked how often they felt worried, 18% said they felt
very worried often or daily, white 68% admitted they felt distressed only at times, and 18% said they never wonted at all.
A total of 25% were afraid they might not reach the hospital
fast enough in an emergency, and one-third of the patients were
concemed that they might ran out of the necessary medicines.
Several patients chose not to travel abroad since they did not
trust foreign medical care in case of emergency. Some said
spontaneously that they were concemed what would happen in
case of war.

Discussion
To advise a candidate for adrenalectomy on which option to
choose, all aspects of quality of life after surgery must be considered. Besides possible medical hazards, patients may face sociat and emotional problems of adaptation. The concept of quality of life must consider physical, social, and emotional facets
(4).
Measurement of quality of life is becoming increasingly
important in medicine (5). In some countries, such as in Sweden, there is a strong trend to make the patient the ultimate decision-maker instead of the physician as has been the tradition in
the past. Regardless of whether the physician has the responsibility of making the final decision in the choice of therapy or is
more of an adviser for the patient, that physician needs a factual
basis of informafion to batance different altematives.
Earlier quatity of life studies have mostiy emphasized objective data (eg, frequency of hospital admissions and dependency
on daily drag intake). Cunent interest is focused more on the
patient's subjective experience—clinical symptoms as welt as
physical, intellectual, and emotional funcfion (inctuding capacity to work, wony, and need for support from medical care personnel and from famity members).
In this study the combined oral and written interview had a
good reproducibility, ie, the answers did not change when the
same question was asked tater. The evaluating instrament should
be able to detect small changes in how the patient values his situation in life. Unfortunately, there is no gold standard as to the
validity of this instrament, ie, how close the relationship is between outcome of the investigation (the answers to the quesfionnaire) and the patient's quatity of life.
Pheochromocytomas if left untreated or if treated too tate
cany a high mortality. To delay or even decline surgery certainly
carries a high risk. In a review of MEN 2 patients in Sweden,
eight of 46 patients with pheochromocytoma died from their
adrenal tumor (6). Most if not atl of these deaths probably could
have been prevented. Today we have methods for earty diagnosis, as well as improved management with an arsenal of alpha-

162

Henry Ford Hosp Med J—Vol 37, Nos 3 & 4, 1989

and beta-receptor blocking drags in combination with modem
anesthesiotogic techniques. We can safety advise surgical treatment for our patients knowing that the benefit in mortality and
morbidity will outweigh the disadvantages of the operation.
However, such arguments do not convince atl patients to proceed with surgery. Some may feel that other aspects such as
quality of life have the greatest impact on this decision rather
than morbidity and mortality. One of our patients has declined
surgery for her pheochromocytoma, which was diagnosed over
ten years ago, because of the hardships her mother suffered after
bilateral adrenalectomy. Her mother had had problems fotlowing instmctions, especially when she had recunent mental depression, and had stopped taking medicine which resulted in
critical situations and threatening collapse. This case was the
background of the present study.
Our conclusion as to prognosis agrees with that of van
Heerden et al (1) in that the overall prognosis after bilateral adrenalectomy is good with low morbidity and mortality. In our series the operative and postoperative mortality was low (one of 27
patients). This man delayed operation for many years since he
was afraid of the disadvantages of a life without adrenal glands.
He is thus an example of those MEN 2 famity members who are
difficult to convince to have adrenalectomy and whose prognosis probably would have been better with early treatment. We
also found serious morbidity to be low with the greatest hazards
experienced by patients who through mental illness or general
carelessness were noncompliant and stopped treatment.
However, morbidity of low or medium severity was more
common, necessitating repeated hospital admissions for invesfigations and metabolic control. Chronic fatigue as well as constant psychologic pressure were described by about one-third of
the patients. A similar number reported that their condition was
such a handicap that they had problems coping with their jobs. It
is possibte and even probable that the cause of fafigue in some of
these patients may be related to other disorders, such as metastasizing medullary thyroid carcinoma.
Apart from being infonned of potential medical hazards, bilaterally adrenalectomized patients must be welt educated about
their condition and the various treatments necessary for different
situafions. Patients must atso be responsible and compliant regarding medication. No doubt the condition is a social and psychological burden with which these patients must cope, but thus
far we have had little knowledge of these social and emofionat
aspects. Quality of life atso includes psychological well-being,
ie, the patients should feet reasonabty secure in their tives. Unfortunately, the extent of medical advice necessary for these patients may have the disadvantage of creating anxiety.
Atl patients in our series had been wett informed that hormone
replacement is essential and that stopping the regular medication
would have serious and life-threatening consequences. This information process is necessary in securing patient compliance
and may be the reason we have seen so few medical complications. However, for some patients this information can create
anxiety, such as wonying that for some reason or another the
suppty of medicines cannot be guaranteed. The intense wony
experienced almost daily by 18% of the patients may in part be a
side effect of the medical education provided by the physician
with the best of intentions. This group may be helped through
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further support and reassurance about the low risks and low incidence of complications.
In general the psychological adaptation was good or very
good in most patients. The patients' adaptation to different practical inconveniences also seemed to be good. Chronic fafigue
interfering with professional work seemed to be the most important side effect.
Medical care for adrenalectomized patients in the countries
studied (Sweden, England, and Kuwait) seems to funcfion welt,
which may be partly due to MEN 2 research and pafient care
attracting many physicians with this special interest.
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